Across TCGA pan-cancer cohorts, RNA5SP202 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNA5SP202’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where RNA5SP202 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNA5SP202 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.
COAD, KIRP, and KIRC are the cancer types where RNA5SP202 tumor–normal differential expression is most reproducible.